Companies Endpoint Clinical, Inc.

Endpoint Clinical, Inc.

Raleigh, North Carolina, USA

Total Offices: 3

650 Total Employees

Year Founded: 2009

View Website

Similar Companies Hiring

Akeneo

eCommerce • Information Technology • Marketing Tech • Software

7 Offices

450 Employees

InterSystems

Artificial Intelligence • Big Data • Healthtech • Machine Learning • Software • Database • Analytics

37 Offices

2407 Employees

Toast

Cloud • Fintech • Food • Information Technology • Software • Hospitality

7 Offices

5000 Employees

Endpoint Clinical, Inc. Company Stability & Growth

Updated on October 22, 2025

This page was generated by Built In using publicly available information and AI-based analysis of common questions about the company. It has not been reviewed or approved by the company.

What's the stability & growth outlook for Endpoint Clinical, Inc.?

Strengths in market leadership, investor-backed capital, and sustained product innovation are accompanied by signs of workforce turbulence during post-acquisition integration and modest near-term scaling. Together, these dynamics suggest a resilient, growth-oriented company with solid competitive positioning, while execution on organizational stability remains an area to monitor.

Positive Themes About Endpoint Clinical, Inc.

Strong Market Position & Advantage: The company is repeatedly characterized as a global leader in RTSM/IRT with substantial operating scale, supporting 2,000+ studies across 90+ countries and 800+ active studies. This breadth and ability to handle complex, global trials provide a durable competitive edge.
Investor Backing & Capital Strength: The June 2024 acquisition by Arsenal Capital Partners supplies focused capital and sponsor support to accelerate expansion and innovation. This backing is presented as validation of market position and a catalyst for the next phase of growth.
Innovation-Driven Growth: Five generations of purpose-built RTSM platforms and the proprietary PULSE platform, including faster study builds in four weeks or less, indicate sustained product advancement. A 2025 brand refresh and continued tech investment underscore a roadmap aimed at pushing RTSM forward.

Considerations About Endpoint Clinical, Inc.

Workforce Instability: Mentions of layoffs and restructuring in 2025 suggest organizational turbulence during the post-acquisition transition. Headcount growth appears modest, indicating limited near-term scaling in some functions.

NEW

What does AI tell candidates about your employer brand?

Get your free AI reputation report today.

See AI Report

The insights on this page are generated by submitting structured prompts to some of the most popular large language models (“LLMs”) and summarizing recurring themes from the responses. Because the insights are generated using AI, they may contain errors. The insights do not necessarily reflect internal data, employee interviews, or verified company information. They may be influenced by incomplete, outdated, or inaccurate data, and may vary across LLM providers. These insights are intended for informational purposes only and should not be interpreted as a factual or definitive assessment of a company's reputation. Built In makes no representations or warranties regarding the accuracy, completeness, or reliability of this information, and disclaims any liability for any actions taken based on this information. If you are a representative of this company, and would like this page to be removed, you may contact us via this form.

Is This Your Company? Claim Profile